Fox Chase Cancer Center Welcomes Dr. Christopher G. Cann

Dr. Cann
Fox Chase Cancer Center is pleased to announce the hiring of Christopher G. Cann, MD, as an assistant professor in the Department of Hematology/Oncology with a focus on gastrointestinal cancers.

PHILADELPHIA (August 15, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Christopher G. Cann, MD, as an assistant professor in the Department of Hematology/Oncology with a focus on gastrointestinal cancers.

Cann earned his undergraduate degree in biology from the University of Maryland, College Park. He then earned his medical degree from the Lewis Katz School of Medicine at Temple University, where he was inducted into the prestigious Alpha Omega Alpha Honor Society and the Gold Humanism Honor Society.

Cann then went on to complete an internal medicine residency and a hematology/oncology fellowship at Vanderbilt University Medical Center. During his years at Vanderbilt, he regularly instructed undergraduates, medical students, residents, and fellows in the classroom and through observation and shadowing programs.

Over the course of his career, Cann has engaged in high-level research, including involvement in clinical trials and publishing in peer-reviewed journals. In 2022, his research was recognized by the American Society of Clinical Oncology (ASCO) with the Conquer Cancer Merit Award. In addition to belonging to ASCO, Cann is a member of the American College of Physicians, the American Medical Association, and the American Society of Hematology.

Cann began his tenure at Fox Chase on August 7.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text